Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries.
Laura E PanattoniMairead KearneyNatalie LandThomas FlottemeschPatrick SullivanMelissa KirkerMurtuza BharmalBrett HauberPublished in: PharmacoEconomics (2024)
While average sample results were consistent with those of prior DCEs, this study found heterogeneity in clinician preferences within and across countries, highlighting the diversity in clinician decision making in oncology.